Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice. - Wikidata - wikimedia - TriplyDB

Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.

Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.

http://www.wikidata.org/entity/Q41817769

about

TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.Monitoring brain tumor vascular heamodynamic following anti-angiogenic therapy with advanced magnetic resonance imaging in mice.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent Serum proteomics in biomedical research: a systematic review.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.Optimization of arterial spin labeling MRI for quantitative tumor perfusion in a mouse xenograft model.Quantitative functional MRI biomarkers improved early detection of colorectal liver metastases.Vitamin B12-induced spermatogenesis recovery in cimetidine-treated rats: effect on the spermatogonia number and sperm concentration.TL-118-anti-angiogenic treatment in pancreatic cancer: a case report.

P2860

Q28540575-1673A615-D57E-4507-A144-236FE166C762 Q34658635-39FE8C23-0ABB-4C4A-A7EA-14843005D508 Q35519732-7F66EDCD-F84D-4527-9D8D-1FF05F1E1E90 Q36483712-38E0826B-245A-4E8E-8B9A-326C9E78A214 Q38101008-88092437-909C-4549-8C24-8493577B26D6 Q38775054-E2C841CE-9BCD-4B10-AB3A-AD036BE0C959 Q38860709-9BDE3B0A-E97C-478B-A254-9C74F64BBEF8 Q39100110-8B464EC7-0F63-4EBE-BEF2-4A2430117D1E Q41486840-025179CB-0FDD-4690-85E2-6023DDA34C25 Q45970215-BA918AE2-0D10-4F65-BAA8-448173557943

P2860

Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.

http://www.wikidata.org/entity/Q41817769

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Improved efficacy of a novel a ...... tases; MRI monitoring in mice.

@en

type

label

Improved efficacy of a novel a ...... tases; MRI monitoring in mice.

@en

prefLabel

Improved efficacy of a novel a ...... tases; MRI monitoring in mice.

@en

P1433

Q41817769-050A6835-0BAE-4396-81D1-F16C2E5A1A38

P1476

Q41817769-CBC860F1-73B6-4191-9AB1-8B695A76B9D2

P2093

Q41817769-CC5FCD46-FEB5-4619-B87B-997C8EBBE93F

Q41817769-D080417A-1B09-45F1-A294-4DEAE3505BC2

Q41817769-D0B226C2-304C-437E-B074-D052D092927C

Q41817769-E1017C46-3C18-477C-8208-0BDE1807D8AD

P2860

Q41817769-04064E85-93EF-4F22-858F-EEF5AA10B595

Q41817769-04FDC349-44D1-4BEA-8614-9DFD21DB54B6

Q41817769-097E9A9C-9C8C-45DF-8AC3-4EEF5F37C8D3

Q41817769-0F6A3F37-19FE-4DBC-9453-8E8A63B2587B

Q41817769-129D3C77-EE26-4D0A-94E7-4287A510DF4E

Q41817769-16EDB68E-9727-478B-B3DB-4F1302BD8940

Q41817769-18D30CE7-2864-49B7-8C90-384239E9BAE2

Q41817769-20DCF8A6-55F5-4550-94BB-C9F8D1736811

Q41817769-21B99D64-C7EA-490F-9C9F-AF0BF20ECA4B

Q41817769-3074E211-695A-4E37-82AC-A12EF30D53E1

P2888

Q41817769-DAE0FD88-310C-4227-8E6C-79FE1EF53CDC

P304

Q41817769-1FE3B5D6-BA22-4D3F-BEDF-BCB11B5DAC07

P31

Q41817769-9C17E8EA-9535-4916-A708-EEF84D32BA2B

P356

Q41817769-40C6901E-911B-4FEC-B78A-20DED3A1967C

P407

Q41817769-422E1C5E-6845-49E3-8EDF-F421C0852BEC

P433

Q41817769-3420237A-7459-43BA-B171-5F06B7DA4435

P478

Q41817769-9838B49C-1894-4055-A402-E06A70AC78BB

P577

Q41817769-D3E32757-6735-46D7-99B2-0727ABC2206F

P5875

Q41817769-D8DB3237-BFBA-4EB1-8727-89D901BFF949

P698

Q41817769-33205893-0810-4E0A-8437-F3B23718004E

P932

Q41817769-96627F76-F2D8-482A-9DC4-20B82B63B5A0

P356

P1433

British Journal of Cancer

P1476

Improved efficacy of a novel a ...... tases; MRI monitoring in mice.

@en

P2093

E Gross

http://www.w3.org/2001/XMLSchema#string

N Corchia

http://www.w3.org/2001/XMLSchema#string

R Abramovitch

http://www.w3.org/2001/XMLSchema#string

Y Edrei

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Nitric oxide: physiology, pathophysiology, and pharmacology

Cancer statistics, 2012

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

What is the evidence that tumors are angiogenesis dependent?

P2888

P304

658-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.322

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229159488

http://www.w3.org/2001/XMLSchema#string

P698

22805330

http://www.w3.org/2001/XMLSchema#string

P932

3419965

http://www.w3.org/2001/XMLSchema#string